Guangdong Hybribio Biotech Co Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Hybribio Biotech Co Ltd with three other
companies in this sector in CHINA :
Getein Biotech Inc
sales of 1.12 billion Chinese Renmimbi [US$173.89 million]
(487.64 million Chinese Renmimbi [US$75.75 million]
Beijing Strong Biotechnologies Inc
(848.12 million Chinese Renmimbi [US$131.76 million]
of which 88%
was In vitro detection reagent).
During the year ended December of 2020, sales at
Guangdong Hybribio Biotech Co Ltd were 1.35 billion Chinese Renmimbi (US$210.42 million).
increase of 85.7%
versus 2019, when the company's sales were 729.39 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guangdong Hybribio Biotech Co Ltd
(and since 2015, sales have increased a total of 293%).
Sales of Medical Testing Servicee saw an increase
that was more than double the company's growth rate: sales were up
498.0% in 2020, from
95.52 million Chinese Renmimbi to 571.20 million Chinese Renmimbi.